VialWatch is a sterile-injectable shortage intelligence platform for hospital pharmacy and procurement teams. Spot supply gaps days earlier, work from a vetted alternative-supplier list, and stop buying from marketing-only middlemen.
No credit card required · Private beta — early users shape the roadmap
The problem
The FDA Drug Shortages list updates after the shortage hits. Industry trade alerts relay it days later. By the time you're searching for an alternative supplier, your competing hospital systems have already locked allocation.
Worse: when you do find an "alternative manufacturer," half the companies on Indiamart and Alibaba are marketing-only firms with no actual GMP-certified finished-dose capability. Verifying takes hours per supplier.
of FDA-listed shortages are sterile injectables
average lag between shortage onset and downstream trade alerts
U.S. hospital cost of drug shortages in 2024 (Vizient)
of "alternative supplier" leads are unverifiable middlemen
Built for procurement teams
A unified, decision-ready view of the full sterile-injectable supply landscape — not raw FDA data dumps.
Every active FDA shortage, drug recall, and new generic approval — categorized, filterable, and updated nightly.
Pro subscribers receive a pre-screened alternative-supplier list per shortage, with regulatory standing and recall history checked before recommendation.
Same-day alerts when watchlisted drugs change status. Cross-referenced relief signals when a new generic enters the market.
Actionable next steps per shortage — what to request, from whom, and why — not 50 search results to read.
Pricing
From free weekly digest to white-glove sourcing reports.
For procurement teams getting started.
For active procurement and supply teams.
For health systems, GPOs, and specialty distributors.
Early access
Get the weekly digest now. We'll let you know when Pro and broker tiers open in your region.